The First Judicial District of Pennsylvania recently granted a motion to create…

Posted on by The First Judicial District of Pennsylvania recently granted a motion to create a Xarelto litigation mass tort program in Philadelphia. This follows the establishment of a Xarelto multidistrict litigation (MDL) in Louisiana in December.

Xarelto is prescribed to treat atrial fibrillation and to reduce blood clot risk. About 130,000 patients were prescribed Xarelto in the U.S. during the first quarter of 2012, according to the Huffington Post.

If you or a loved one experienced bleeding from Xarelto, contact a PLG today to find out if you qualify for compensation. Filing a Xarelto lawsuit can force the manufacturers to take responsibility for injuries caused by the dangerous drug.

Comments are closed.